Analysis of Profitability Ratios
Profitability ratios measure the company ability to generate profitable sales from its resources (assets).
Profitability Ratios (Summary)
Becton, Dickinson & Co., profitability ratios
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
| Profitability ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Becton, Dickinson & Co. gross profit margin ratio deteriorated from 2019 to 2020 but then improved from 2020 to 2021 not reaching 2019 level. |
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Becton, Dickinson & Co. operating profit margin ratio deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level. |
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Becton, Dickinson & Co. net profit margin ratio deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level. |
| Profitability ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Becton, Dickinson & Co. ROE deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level. |
| ROA | A profitability ratio calculated as net income divided by total assets. | Becton, Dickinson & Co. ROA deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level. |
Gross Profit Margin
Becton, Dickinson & Co., gross profit margin calculation, comparison to benchmarks
| Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||
| Gross profit | 9,427) | 7,577) | 8,288) | 7,262) | 5,942) | 5,991) | |
| Revenues | 20,248) | 17,117) | 17,290) | 15,983) | 12,093) | 12,483) | |
| Profitability Ratio | |||||||
| Gross profit margin1 | 46.56% | 44.27% | 47.94% | 45.44% | 49.14% | 47.99% | |
| Benchmarks | |||||||
| Gross Profit Margin, Competitors2 | |||||||
| Abbott Laboratories | 52.21% | 50.49% | 52.46% | — | — | — | |
| Cigna Group | 12.41% | 14.43% | 15.57% | — | — | — | |
| CVS Health Corp. | 17.48% | 18.01% | 17.41% | — | — | — | |
| Elevance Health Inc. | 17.09% | 19.71% | 18.77% | — | — | — | |
| Intuitive Surgical Inc. | 69.32% | 65.65% | 69.45% | — | — | — | |
| Medtronic PLC | 65.19% | 67.41% | 70.04% | 69.77% | — | — | |
| Shockwave Medical Inc. | 82.53% | 69.03% | 60.03% | — | — | — | |
| UnitedHealth Group Inc. | 23.60% | 25.62% | 23.19% | — | — | — | |
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
1 2021 Calculation
Gross profit margin = 100 × Gross profit ÷ Revenues
= 100 × 9,427 ÷ 20,248 = 46.56%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Becton, Dickinson & Co. gross profit margin ratio deteriorated from 2019 to 2020 but then improved from 2020 to 2021 not reaching 2019 level. |
Operating Profit Margin
Becton, Dickinson & Co., operating profit margin calculation, comparison to benchmarks
| Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||
| Operating income | 2,799) | 1,484) | 1,760) | 1,497) | 1,478) | 1,430) | |
| Revenues | 20,248) | 17,117) | 17,290) | 15,983) | 12,093) | 12,483) | |
| Profitability Ratio | |||||||
| Operating profit margin1 | 13.82% | 8.67% | 10.18% | 9.37% | 12.22% | 11.46% | |
| Benchmarks | |||||||
| Operating Profit Margin, Competitors2 | |||||||
| Abbott Laboratories | 19.56% | 15.48% | 14.21% | — | — | — | |
| Cigna Group | 4.60% | 5.12% | 5.31% | — | — | — | |
| CVS Health Corp. | 4.54% | 5.19% | 4.69% | — | — | — | |
| Elevance Health Inc. | 5.15% | 4.97% | 5.49% | — | — | — | |
| Humana Inc. | 3.80% | 6.56% | 4.96% | — | — | — | |
| Intuitive Surgical Inc. | 31.89% | 24.09% | 30.69% | — | — | — | |
| Medtronic PLC | 14.89% | 16.57% | 20.51% | 22.20% | — | — | |
| Shockwave Medical Inc. | -0.37% | -96.86% | -120.76% | — | — | — | |
| UnitedHealth Group Inc. | 8.40% | 8.76% | 8.19% | — | — | — | |
| Operating Profit Margin, Sector | |||||||
| Health Care Equipment & Services | 6.68% | 7.03% | 6.88% | — | — | — | |
| Operating Profit Margin, Industry | |||||||
| Health Care | 13.18% | 10.47% | 12.44% | — | — | — | |
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
1 2021 Calculation
Operating profit margin = 100 × Operating income ÷ Revenues
= 100 × 2,799 ÷ 20,248 = 13.82%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Becton, Dickinson & Co. operating profit margin ratio deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level. |
Net Profit Margin
Becton, Dickinson & Co., net profit margin calculation, comparison to benchmarks
| Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||
| Net income | 2,092) | 874) | 1,233) | 311) | 1,100) | 976) | |
| Revenues | 20,248) | 17,117) | 17,290) | 15,983) | 12,093) | 12,483) | |
| Profitability Ratio | |||||||
| Net profit margin1 | 10.33% | 5.11% | 7.13% | 1.95% | 9.10% | 7.82% | |
| Benchmarks | |||||||
| Net Profit Margin, Competitors2 | |||||||
| Abbott Laboratories | 16.42% | 12.99% | 11.56% | — | — | — | |
| Cigna Group | 3.11% | 5.31% | 3.35% | — | — | — | |
| CVS Health Corp. | 2.72% | 2.68% | 2.59% | — | — | — | |
| Elevance Health Inc. | 4.46% | 3.78% | 4.66% | — | — | — | |
| Humana Inc. | 3.54% | 4.43% | 4.20% | — | — | — | |
| Intuitive Surgical Inc. | 29.85% | 24.33% | 30.80% | — | — | — | |
| Medtronic PLC | 11.97% | 16.56% | 15.16% | 10.36% | — | — | |
| Shockwave Medical Inc. | -3.85% | -96.92% | -119.06% | — | — | — | |
| UnitedHealth Group Inc. | 6.06% | 6.03% | 5.76% | — | — | — | |
| Net Profit Margin, Sector | |||||||
| Health Care Equipment & Services | 4.96% | 5.20% | 4.84% | — | — | — | |
| Net Profit Margin, Industry | |||||||
| Health Care | 10.89% | 7.77% | 10.20% | — | — | — | |
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
1 2021 Calculation
Net profit margin = 100 × Net income ÷ Revenues
= 100 × 2,092 ÷ 20,248 = 10.33%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Becton, Dickinson & Co. net profit margin ratio deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level. |
Return on Equity (ROE)
Becton, Dickinson & Co., ROE calculation, comparison to benchmarks
| Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||
| Net income | 2,092) | 874) | 1,233) | 311) | 1,100) | 976) | |
| Shareholders’ equity | 23,677) | 23,765) | 21,081) | 20,994) | 12,948) | 7,633) | |
| Profitability Ratio | |||||||
| ROE1 | 8.84% | 3.68% | 5.85% | 1.48% | 8.50% | 12.79% | |
| Benchmarks | |||||||
| ROE, Competitors2 | |||||||
| Abbott Laboratories | 19.75% | 13.71% | 11.86% | — | — | — | |
| Cigna Group | 11.39% | 16.81% | 11.26% | — | — | — | |
| CVS Health Corp. | 10.54% | 10.35% | 10.39% | — | — | — | |
| Elevance Health Inc. | 16.93% | 13.77% | 15.15% | — | — | — | |
| Humana Inc. | 18.24% | 24.53% | 22.49% | — | — | — | |
| Intuitive Surgical Inc. | 14.32% | 10.90% | 16.69% | — | — | — | |
| Medtronic PLC | 7.01% | 9.44% | 9.25% | 6.12% | — | — | |
| Shockwave Medical Inc. | -3.78% | -29.11% | -26.53% | — | — | — | |
| UnitedHealth Group Inc. | 24.09% | 23.52% | 24.02% | — | — | — | |
| ROE, Sector | |||||||
| Health Care Equipment & Services | 15.04% | 15.13% | 14.24% | — | — | — | |
| ROE, Industry | |||||||
| Health Care | 23.00% | 16.14% | 21.17% | — | — | — | |
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
1 2021 Calculation
ROE = 100 × Net income ÷ Shareholders’ equity
= 100 × 2,092 ÷ 23,677 = 8.84%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Becton, Dickinson & Co. ROE deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level. |
Return on Assets (ROA)
Becton, Dickinson & Co., ROA calculation, comparison to benchmarks
| Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||
| Net income | 2,092) | 874) | 1,233) | 311) | 1,100) | 976) | |
| Total assets | 53,866) | 54,012) | 51,765) | 53,904) | 37,734) | 25,586) | |
| Profitability Ratio | |||||||
| ROA1 | 3.88% | 1.62% | 2.38% | 0.58% | 2.92% | 3.81% | |
| Benchmarks | |||||||
| ROA, Competitors2 | |||||||
| Abbott Laboratories | 9.40% | 6.20% | 5.43% | — | — | — | |
| Cigna Group | 3.46% | 5.44% | 3.28% | — | — | — | |
| CVS Health Corp. | 3.39% | 3.11% | 2.98% | — | — | — | |
| Elevance Health Inc. | 6.26% | 5.28% | 6.21% | — | — | — | |
| Humana Inc. | 6.61% | 9.63% | 9.31% | — | — | — | |
| Intuitive Surgical Inc. | 12.58% | 9.50% | 14.17% | — | — | — | |
| Medtronic PLC | 3.87% | 5.28% | 5.16% | 3.40% | — | — | |
| Shockwave Medical Inc. | -2.64% | -24.15% | -22.04% | — | — | — | |
| UnitedHealth Group Inc. | 8.15% | 7.81% | 7.96% | — | — | — | |
| ROA, Sector | |||||||
| Health Care Equipment & Services | 5.62% | 5.60% | 5.17% | — | — | — | |
| ROA, Industry | |||||||
| Health Care | 8.24% | 5.46% | 7.22% | — | — | — | |
Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).
1 2021 Calculation
ROA = 100 × Net income ÷ Total assets
= 100 × 2,092 ÷ 53,866 = 3.88%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| ROA | A profitability ratio calculated as net income divided by total assets. | Becton, Dickinson & Co. ROA deteriorated from 2019 to 2020 but then improved from 2020 to 2021 exceeding 2019 level. |